$CLRB
Cellectar Biosciences INC NEW
XNAS•Health Care•Pharmaceutical Preparations
$2.38
▼-0.83%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCellectar Biosciences INC NEW
XNAS•Health Care•Pharmaceutical Preparations
Why is CLRB down today? It is at $2.38 (-0.83%). See the catalyst behind the move, real-time alerts the moment CLRB spikes, and full due diligence on CLRB — key stats, earnings, dilution and insider activity. Free.
Be first to know when $CLRB makes an unusual move. Create a free account to track $CLRB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CLRB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLRB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystReports Second Quarter 2026 Financial Results and Provides Corporate UpdatesReported 100% clinical benefit rateReported 87.5% overall response rate (ORR)Reported 79.2% MRR, partial response (PR) or better, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Caruso James V Officer | Bought (open market) | +9K 0.09% of company | added 75% | 20K | $25K at $2.88 | May 7, 26 |
Longcor Jarrod Officer | Bought (open market) | +9K 0.09% of company | added 74% | 20K | $25K at $2.88 | May 7, 26 |
Neis John Director | Sold (automatic/other) | -198 | sold 95% | 10 | $733 at $3.70 | Dec 12, 25 |
Kolean Chad J Officer | Bought (open market) | +5K 0.05% of company | added 100% | 6K | $25K at $4.99 | Jul 2, 25 |
Longcor Jarrod Officer | Bought (open market) | +10K 0.1% of company | added 100% | 13K | $50K at $4.99 | Jul 2, 25 |
Caruso James V Officer | Bought (open market) | +10K 0.1% of company | added 100% | 12K | $50K at $4.99 | Jul 2, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CLRB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLRB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CLRB last traded at $2.38, down 0.83% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cellectar Biosciences INC NEW (CLRB) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CLRB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLRB 0 times in the last 30 days.
CLRB (Cellectar Biosciences INC NEW) trades on XNAS, with a market cap of about $22M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLRB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLRB discussion
Sign in to ask a question or join the discussion.